Rare Cancers
FY23 Ad Hoc Programmatic Reviewers:
Ruth Aiwu He, M.D., Ph.D.
Georgetown University School of Medicine
Andrew Lane, M.D., Ph.D.
Dana-Farber Cancer Institute
Steven Sizemore, Ph.D.
The Ohio State University
Last updated Monday, April 8, 2024